TapewireFind a company

person · Reporting owner

Pelizzon David R

Disclosed activity across 2 companies

Tapewire entity
10099
SEC CIK
0001719217

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Alphatec Holdings, Inc.ATEC · Entity 4720DirectorJune 10, 2026June 12, 2026
ORTHOPEDIATRICS CORPKIDS · Entity 5338Director · 10% ownerSeptember 10, 2026September 10, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Alphatec Holdings, Inc.

Report date June 10, 2026 · Filed June 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect378,839 Reported balance After 2026-06-10 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-06-10 · Grant · Acquired 32,012 · Balance 378,839

F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Common StockSEC Table I · non-derivativeIndirectBy Squadron Capital LLC10,395,045 Reported balance Holding disclosure · report date 2026-06-10 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 10,395,045

F2: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F2: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

ORTHOPEDIATRICS CORP

Report date September 10, 2026 · Filed September 10, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnote6,201,764 Reported balance After 2026-09-10 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2026-09-10 · Sale · Disposed 302,369 · Balance 6,201,764

F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Common StockSEC Table I · non-derivativeDirect44,384 Reported balance Holding disclosure · report date 2026-09-10 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 44,384

F4: Includes restricted stock awards totaling 17,959 shares.

Filing footnotes · ownership attribution and instrument terms

F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

F4: Includes restricted stock awards totaling 17,959 shares.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 10, 2026 Filed Sep 10, 2026 20:21 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 302,369 $21.01 $6,352,772.69
Disclosure

SEC source: 0001425450-26-000087 · wk-form4_1789071671.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,201,764

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:26 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 22,500 $23.35 $525,375.00
Disclosure

SEC source: 0001425450-26-000085 · wk-form4_1788553597.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,504,133

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:13 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 10,131 $23.10 $234,026.10
Disclosure

SEC source: 0001425450-26-000083 · wk-form4_1788297228.xml · nonDerivative · entry 2

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,526,633

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
August 28, 2026 Filed Sep 1, 2026 21:13 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 326,700 $23.04 $7,527,168.00
Disclosure

SEC source: 0001425450-26-000083 · wk-form4_1788297228.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,536,764

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
August 26, 2026 Filed Aug 26, 2026 22:17 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 18,000 $24.28 $437,040.00
Disclosure

SEC source: 0001425450-26-000081 · wk-form4_1787782652.xml · nonDerivative · entry 3

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,863,464

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote

F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
August 25, 2026 Filed Aug 26, 2026 22:17 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 16,300 $24.74 $403,262.00
Disclosure

SEC source: 0001425450-26-000081 · wk-form4_1787782652.xml · nonDerivative · entry 2

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,881,464

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
August 24, 2026 Filed Aug 26, 2026 22:17 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 4,000 $25.75 $103,000.00
Disclosure

SEC source: 0001425450-26-000081 · wk-form4_1787782652.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 6,897,764

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 21:30 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 GrantCommon Stock 32,012 $0.00 $0.00
Disclosure

SEC source: 0001719217-26-000002 · form4-06122026_050606.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378,839

F1 · security: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · kind: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 09, 2026 Filed Jun 10, 2026 13:54 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GrantCommon Stock 11,436 $0.00 $0.00
Disclosure

SEC source: 0001425450-26-000061 · wk-form4_1781099658.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,384

F1 · balance_after: Includes restricted stock awards totaling 17,959 shares.

Read SEC document
December 16, 2025 Filed Dec 19, 2025 00:28 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 SaleCommon Stock 250,000 $19.66 $4,915,000.00
Disclosure

SEC source: 0001719217-25-000009 · form4-12192025_121237.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Squadron Capital LLC

Disclosed balance after: 10,395,045

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.33 to $19.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 00:00 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 SaleCommon Stock 28,834 $21.03 $606,379.02
Disclosure

SEC source: 0001719217-25-000007 · form4-12102025_071210.xml · nonDerivative · entry 2

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Squadron Capital LLC

Disclosed balance after: 10,645,045

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:00 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 SaleCommon Stock 221,166 $21.20 $4,688,719.20
Disclosure

SEC source: 0001719217-25-000007 · form4-12102025_071210.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Squadron Capital LLC

Disclosed balance after: 10,673,879

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 00:00 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 SaleCommon Stock 250,000 $20.62 $5,155,000.00
Disclosure

SEC source: 0001719217-25-000005 · form4-11252025_071103.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Squadron Capital LLC

Disclosed balance after: 10,895,045

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.34 to $20.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 21:36 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 SaleCommon Stock 250,000 $20.80 $5,200,000.00
Disclosure

SEC source: 0001719217-25-000003 · form4-11142025_091108.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Squadron Capital LLC

Disclosed balance after: 11,145,045

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.67 to $21.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 21:30 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 GrantCommon Stock 15,131 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017264 · form4-06132025_050607.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,827

F1 · security: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · kind: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
May 23, 2025 Filed May 28, 2025 12:52 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GrantCommon Stock 8,401 $0.00 $0.00
Disclosure

SEC source: 0001425450-25-000065 · wk-form4_1748436733.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,948

F1 · balance_after: Includes restricted stock awards totaling 10,900 shares.

Read SEC document
August 23, 2024 Filed Aug 26, 2024 20:27 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 16,978 $5.89 $100,000.42
Disclosure

SEC source: 0001415889-24-022226 · form4-08262024_080822.xml · nonDerivative · entry 2

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 331,696

Read SEC document
August 22, 2024 Filed Aug 26, 2024 20:27 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 8,818 $5.67 $49,998.06
Disclosure

SEC source: 0001415889-24-022226 · form4-08262024_080822.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,718

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:30 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 GrantCommon Stock 16,747 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-016930 · form4-06142024_040614.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,900

F1 · security: On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · kind: On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 12, 2024, issuer granted to the reporting person 16,747 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
May 28, 2024 Filed May 30, 2024 20:41 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GrantCommon Stock 2,766 $0.00 $0.00
Disclosure

SEC source: 0001425450-24-000047 · wk-form4_1717101683.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,547

F1 · balance_after: Includes restricted stock awards totaling 4,640 shares.

Read SEC document
June 20, 2023 Filed Jun 22, 2023 00:05 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 GrantCommon Stock 9,908 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-010124 · form4-06222023_120610.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,153

F1 · security: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · kind: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 14, 2023 Filed Jun 15, 2023 19:32 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GrantCommon Stock 1,965 $0.00 $0.00
Disclosure

SEC source: 0001425450-23-000082 · wk-form4_1686857532.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,781

F1 · balance_after: Includes restricted stock awards totaling 3,560 shares.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 20:45 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 3,100 $15.24 $47,244.00
Disclosure

SEC source: 0000899243-23-008574 · doc4.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,245

Read SEC document
September 20, 2022 Filed Sep 22, 2022 11:31 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 OtherWarrants (right to buy) · Derivative 1,525,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-22-031659 · doc4.xml · derivative · entry 3

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,525,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days.

F2 · derivative.expiration_date: Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days.

F1 · ownership.nature: These securities are held directly by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
September 20, 2022 Filed Sep 22, 2022 11:31 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 OtherCommon Stock 1,525,000 $0.00 $457.50
Disclosure

SEC source: 0000899243-22-031659 · doc4.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 6,901,764

F1 · ownership.nature: These securities are held directly by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
September 06, 2022 Filed Feb 3, 2023 22:56 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 GiftCommon Stock 31,250 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-003915 · doc5.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,145

Read SEC document
September 02, 2022 Filed Feb 3, 2023 22:55 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GiftCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-003913 · doc5.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,816

Read SEC document
August 11, 2022 Filed Aug 15, 2022 21:38 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 PurchaseWarrants (right to buy) · Derivative 1,525,000 $55.00 Strike: $0.00 $83,874,695.00
Disclosure

SEC source: 0000899243-22-028657 · doc4.xml · derivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,525,000

Underlying: Common Stock · 1,525,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Squadron Capital LLC ("Squadron") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days.

F1 · derivative.expiration_date: Squadron Capital LLC ("Squadron") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days.

F2 · ownership.nature: These securities are held directly by Squadron. As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 19:30 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 GrantCommon Stock 18,546 $0.00 $0.00
Disclosure

SEC source: 0001179110-22-003360 · edgar.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,395

F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 12:17 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GrantCommon Stock 1,691 $0.00 $0.00
Disclosure

SEC source: 0001425450-22-000070 · wf-form4_165425862720437.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,816

F1 · balance_after: Includes restricted stock awards totaling 3,092 shares.

Read SEC document
November 11, 2021 Filed Nov 12, 2021 20:29 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 PurchaseCommon Stock 825 $66.48 $54,846.00
Disclosure

SEC source: 0001425450-21-000155 · wf-form4_163674896073977.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,125

F1 · shares: Represents shares purchased by Mr. Pelizzon in the open market.

F2 · balance_after: Includes restricted stock awards totaling 2,801 shares.

Read SEC document
November 11, 2021 Filed Nov 16, 2021 00:02 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 4,366 $11.41 $49,816.06
Disclosure

SEC source: 0001179110-21-010133 · edgar.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,849

Read SEC document
November 08, 2021 Filed Nov 10, 2021 19:38 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 5,425 $13.00 $70,525.00
Disclosure

SEC source: 0001179110-21-010028 · edgar.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,483

Read SEC document
June 16, 2021 Filed Jun 21, 2021 22:29 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-025076 · doc4.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,058

F1 · shares: On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date.

F1 · price: On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 18:30 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GrantCommon Stock 1,400 $0.00 $0.00
Disclosure

SEC source: 0001425450-21-000097 · wf-form4_162283140859682.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,300

F1 · balance_after: Includes restricted stock awards totaling 2,801 shares.

Read SEC document
May 10, 2021 Filed May 12, 2021 21:25 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 120,000 $15.25 $1,830,000.00
Disclosure

SEC source: 0000899243-21-019280 · doc4.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,837

Read SEC document
March 15, 2021 Filed Mar 17, 2021 14:00 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 PurchaseCommon Stock 3,700 $46.50 $172,050.00
Disclosure

SEC source: 0001425450-21-000053 · wf-form4_161598958771882.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,900

F1 · shares: Represents shares purchased by Mr. Pelizzon in the open market.

Read SEC document
March 08, 2021 Filed Mar 10, 2021 21:48 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 695 $15.93 $11,071.35
Disclosure

SEC source: 0000899243-21-010986 · doc4.xml · nonDerivative · entry 2

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,837

Read SEC document
March 08, 2021 Filed Mar 10, 2021 21:48 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 4,003 $15.50 $62,046.50
Disclosure

SEC source: 0000899243-21-010986 · doc4.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,142

Read SEC document
March 01, 2021 Filed Mar 3, 2021 22:10 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 8,100,810 $11.11 $89,999,999.10
Disclosure

SEC source: 0000899243-21-009425 · doc4.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Squadron Capital LLC

Disclosed balance after: 11,395,045

F1 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As one of two members of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
December 18, 2020 Filed Dec 22, 2020 23:45 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 GrantCommon Stock 1,350,135 $11.11 $14,999,999.85
Disclosure

SEC source: 0001179110-20-012195 · edgar.xml · nonDerivative · entry 2

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Squadron Capital LLC

Disclosed balance after: 2,437,092

F1 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
October 16, 2020 Filed Jan 26, 2021 19:15 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 PurchaseCommon Stock 857,143 $8.75 $7,500,001.25
Disclosure

SEC source: 0001179110-21-000832 · edgar.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Squadron Capital LLC

Disclosed balance after: 3,294,235

F1 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
June 19, 2020 Filed Jun 22, 2020 19:22 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 Exercise / conversionStock Option (Right to Buy) · Derivative 1,340 $30.97 Strike: $30.97 $41,499.80
Disclosure

SEC source: 0001425450-20-000093 · wf-form4_159285370887898.xml · derivative · entry 3

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,340 shares

Expires 2022-08-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option is fully vested and immediately exercisable.

F3 · ownership.nature: These shares of Common Stock and stock option are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares of Common Stock and stock option. The reporting person expressly disclaims beneficial ownership of these shares of Common Stock and stock option, except to the extent of his pecuniary interest therein. The inclusion of these shares of Common Stock and stock option in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
June 19, 2020 Filed Jun 22, 2020 19:22 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 Exercise / conversionCommon Stock 1,340 $30.97 $41,499.80
Disclosure

SEC source: 0001425450-20-000093 · wf-form4_159285370887898.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 5,376,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

Read SEC document
June 17, 2020 Filed Jun 19, 2020 21:08 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 GrantCommon Stock 21,142 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-007647 · edgar.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,139

F1 · security: On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date.

F1 · shares: On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date.

F1 · price: On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date.

F1 · balance_after: On June 17, 2020, issuer granted to the reporting person 21,142 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 19:34 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GrantCommon Stock 1,400 $0.00 $0.00
Disclosure

SEC source: 0001425450-20-000077 · wf-form4_159129923744914.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,200

F1 · balance_after: Includes restricted stock awards totaling 2,801 shares.

Read SEC document
June 05, 2019 Filed Jun 7, 2019 19:04 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GrantCommon Stock 1,400 $0.00 $0.00
Disclosure

SEC source: 0001425450-19-000065 · wf-form4_155993426688429.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,800

F1 · balance_after: Includes restricted stock awards totaling 2,334 shares.

Read SEC document
June 20, 2018 Filed Jun 22, 2018 21:01 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 GrantCommon Stock 1,400 $0.00 $0.00
Disclosure

SEC source: 0001425450-18-000086 · wf-form4_152970125333171.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,400

F1 · balance_after: Includes restricted stock awards totaling 1,400 shares.

Read SEC document
May 22, 2018 Filed May 24, 2018 18:44 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 PurchaseCommon Stock 2,000 $19.50 $39,000.00
Disclosure

SEC source: 0001425450-18-000072 · wf-form4_152718742764554.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

F1 · shares: Represents shares purchased by Mr. Pelizzon in the open market.

Read SEC document
March 12, 2018 Filed Mar 13, 2018 21:09 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 PurchaseCommon Stock 1,000 $17.50 $17,500.00
Disclosure

SEC source: 0001425450-18-000037 · wf-form4_152097534718300.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

F1 · shares: Represents shares that were purchased by Mr. Pelizzon in the open market.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.